AI Insight
The first E-STAR annual report provides comprehensive data on early access to kidney transplantation in the United States, where over 800,000 people live with end-stage kidney disease. The report highlights that while kidney transplantation is the optimal treatment offering better survival rates and quality of life compared to dialysis, significant barriers continue to prevent many eligible patients from accessing the full transplantation process. The analysis addresses organ shortages and systemic obstacles that keep patients on dialysis rather than receiving transplants.
Why it matters
This report identifies critical access barriers in the kidney transplantation system, which could inform policy changes and interventions to improve equity in transplant access. Understanding these obstacles is essential for developing strategies to help more of the hundreds of thousands of Americans with end-stage kidney disease receive life-saving transplants.
Understand the Science
Chronic kidney disease affects millions of Americans, and more than 800,000 people in the United States are living with end-stage kidney disease. While kidney transplantation is widely recognized as the preferred treatment for eligible patients, offering longer survival and improved quality of life, many remain on dialysis because of organ shortages and barriers that limit access to all steps in the process of receiving a transplant.
Source: First E-STAR annual report offers unprecedented view of early access to kidney transplantation